RSPH holds a portfolio of health care companies from the S&P 500. Instead of weighting its holdings by market cap, RSPH uses an equal-weighting scheme. The result is a portfolio that does not deviate much from the broad US health care market but is still far less concentrated than the industry with a skew toward midcaps. This causes profound industry tilts, though it doesn't necessarily add more risk. With less concentration in pharma, RSPH provides more balanced exposure to other industries within the health care sector such as equipment & supplies, healthcare providers, and drug retailers. The index is rebalanced on a quarterly basis. Prior to June 07, 2023, the fund traded under the ticker, RYH.